PubMed:32809870 JSONTXT 21 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function

Id Subject Object Predicate Lexical cue
T1 0-83 Sentence denotes MATH+ protocol for the treatment of SARS-CoV-2 infection: the scientific rationale.
T2 84-162 Sentence denotes INTRODUCTION: COVID-19 disease progresses through a number of distinct phases.
T3 163-215 Sentence denotes The management of each phase is unique and specific.
T4 216-418 Sentence denotes The pulmonary phase of COVID-19 is characterized by an organizing pneumonia with profound immune dysregulation, activation of clotting, and a severe microvascular injury culminating in severe hypoxemia.
T5 419-579 Sentence denotes The core treatment strategy to manage the pulmonary phase includes the combination of methylprednisolone, ascorbic acid, thiamine, and heparin (MATH+ protocol).
T6 580-643 Sentence denotes The rationale for the MATH+ protocol is reviewed in this paper.
T7 644-658 Sentence denotes AREAS COVERED:
T8 659-875 Sentence denotes We provide an overview on the pathophysiological changes occurring in patients with COVID-19 respiratory failure and a treatment strategy to reverse these changes thereby preventing progressive lung injury and death.
T9 876-891 Sentence denotes EXPERT OPINION:
T10 892-1480 Sentence denotes While there is no single 'Silver Bullet' to cure COVID-19, we believe that the severely disturbed pathological processes leading to respiratory failure in patients with COVID-19 organizing pneumonia will respond to the combination of Methylprednisone, Ascorbic acid, Thiamine, and full anticoagulation with Heparin (MATH+ protocol).We believe that it is no longer ethically acceptable to limit management to 'supportive care' alone, in the face of effective, safe, and inexpensive medications that can effectively treat this disease and thereby reduce the risk of complications and death.